Recruiting PHASE4 INTERVENTIONAL 2-arm NCT03144206

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

Randomized Pilot Study Evaluating Hyperbaric Oxygen Therapy Following Management of Soft Tissue Sarcoma With Neo-adjuvant Radiation and Surgical Resection

Sponsor: Duke University

Conditions Hyperbaric Oxygen Therapy Sarcoma

Interventions Hyperbaric oxygen

Updated 12 times since 2017 Last updated: Jul 7, 2025 Started: Oct 19, 2017 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03144206, this PHASE4 trial focuses on Hyperbaric Oxygen Therapy and Sarcoma and remains actively recruiting participants. Sponsored by Duke University, it has been updated 12 times since 2017, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

12 versions recorded

Aug 2025 — Present [monthly]

Recruiting PHASE4
Sep 2024 — Aug 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Aug 2023 — Jul 2024 [monthly]

Recruiting PHASE4
Feb 2022 — Aug 2023 [monthly]

Recruiting PHASE4

▶ Show 7 earlier versions

Feb 2021 — Feb 2022 [monthly]

Recruiting PHASE4
Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE4
Jan 2020 — Jan 2021 [monthly]

Recruiting PHASE4
Nov 2018 — Jan 2020 [monthly]

Recruiting PHASE4
Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE4
Feb 2018 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jul 2017 — Feb 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke University

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States